Introduction: Kaposi's sarcoma (KS) is a kind of cancer that causes flat or raised lesions containing Human herpes virus 8 (HHV8). The KS lesions
Introduction
Current studies indicate that all types of Kaposi's sarcoma (KS) are caused by Human Herpes Virus (HHV)-8 infections, and the difference in them is attributed by the contributions of many cofactors [1] .
Genetic or environmental factors are essential for progression of KS resulting to heterogeneous circulation of the virus in different populations [2] . Immunosuppression due to Human
Immunodeficiency Virus (HIV)-1 can result in the manifestation of Kaposi's sarcoma tumors [3] . The genome of HHV-8 is about 140.5
Kilo base pair, and encompasses several terminal repeats [4] . The naming of HHV-8 genes is based on the genomic location, and the letter 'K' is deduced from Kaposi's sarcoma human virus (KSHV) [5] .
The HHV-8 genes have been observed to play a role in the KS pathogenesis. K1 gene stimulates and augments other cells in a paracrine manner. Manifestation of KS is heightened when K1 gene which encodes for inflammation unites with the HIV-1 Tat protein [6] .
K15 gene is located at the right end of HHV-8 genome and occurs in two alleles as P (Predominant) and M (minor). It has been shown to contribute to the angiogenic properties of the KSHV [7] . Viral pathogenesis of HHV-8 associated KS has been attributed to the interactions between host immune responses, K1 and K15 genes. In addition, K1 and K15 genes have also been detected in cells during latency period and have been linked to viral neoplasia [8] . The geographical distribution of HHV-8 has been well defined. However, what remains a puzzle is the reason for its high prevalence in Africa and Middle East and a relatively lower prevalence in United States and Northern Europe [9] . Studies have suggested the possibility of HHV-8 being transmitted through oral-fecal route but this still yet to be established [10] . The precise mode of transmission of HHV-8 is still not known but, the virus has been successfully detected in semen and saliva [11] . It is not recommended to test children and adults on a routine basis, for this reason the serological status of HHV-8 in patients infected with HIV is frequently unknown [12] . results from a nationally representative study [17] , q = 0.944, d^2 = 0.05^2, n = 1.962 X ((0.056) X (1-0.056))/(0.05)^2 = 81. The data was analyzed using SPSS version 21 where the relationship between K1, K15 (P) genes and clinicopathologic factors were tested by chisquare, multiple logistic analysis and t-test. A P value < 0.05 was considered statistically significant.
Results
The K1 and K15 (P) genes detected as positive were 88.9% (72/81) and negative was 11.1% (9/81). Among the 88.9% tissue bocks that were positive for the targeted HHV-8 genes, 41.7% (30/72) were from female and 58.3% (30/72) male. All the subjects whose tissue blocks were retrieved for this study were found to be HIV positive.
The antiretroviral status of the subjects was also determined, and it showed that out of the 88.9% that had K1 and K15 (P) genes detected, 95.8% (69/72) were on antiretroviral treatment and 4.2 (Table 1 ) was done to determine the prevalence odds ratio and this model was found to be significant at P value of < 0.007.
Discussion
Genotyping analysis in this study revealed that the Kaposi's sarcomaassociated herpes virus (KSHV) genes, K1 and K15 (P) were detected
Page number not for citation purposes 4 among the selected tissue blocks. These findings affirm the earlier hypothesis that K1 and K15 (P) genes of Kaposi's sarcoma-associated herpes virus (KSHV) were present in the tissue blocks retrieved from patients with HIV-1 and AIDS. A previous study [18] conducted at the same facility looked at the prevalence of KS and it was noted that the existence was ranging from 2-5%. The discrepancy could be attributed to the number of cases as the previous study had total of 1108 cases of KS consisting of 911 males and 197 females. It is worth noting that unlike the former study that used clinical and histological diagnosis, the current study adopted the use of a more sensitive test that detected HHV-8 Deoxyribonucleic acid (DNA). In Morocco, an epidemiology study on Kaposi's sarcoma showed that they successfully detected the K1 gene at 870 bp in 35/35 DNA samples and K15 (P) was spotted in 31/35 using 362 bp PCR product [19] . In Zambia, the K1 sequences were detected in blood from HIV positive febrile infants who had KS. The study went further and did a distinct grouping of KS strains and it was noted that K1 glycoprotein was highly variable [20] . A study on the evolution of K15 gene and HHV-8 recombination was done in Uganda and the findings indicated that K15 was highly divergent with P allele being predominant in 30/30 KS patients. The whole K15 gene (2101 bp) was used in the analysis to establish the existence of HHV-8 [21] . In Zimbabwe, the existence of K1 diversity was evaluated and it was observed that there was no significant relationship that was found to exist amongst K1 subtypes and the clinico-demographic features among the 65 AIDS-KS patients [22] . The results of this study will add to the literature on the existing list of countries that have successfully detected K1 and K15 (P) genes associated with AIDS-KS in Africa. The crude prevalence odds ratio (POR) from Table 1 indicated that none of the variables were found significant (P < 0.05); but some variables like gender, CD4 cell count, treatment and distribution of KS lesions showed a strength in the association: gender for example, we noticed that compared to females, males were twice represented among those with K1 and K5 (P) genes cases.
These findings were in agreement with another study [23] where it was observed that in Africa, tumors associated with KS were likely to be diagnosed in male patients. From the registry records where the bio-data and clinical information of the patients, whose tissue blocks were used in this study, none had a CD4 count above 350 cell/ mm 3 .
Other studies [24, 25] have also indicated that CD4 cell count <350 cells/ mm 3 are linked to high risk of developing KS whether one is on HIV treatment or not. However, recommendations have been made on the need to lookout on KS cases in subjects with high CD4 cell count [24] . For treatment, HAART naive group in this study were found to be twice represented among the K1 and K5 (P) genes cases compared to those on treatment. Typically, when a patient with AIDS associated KS adheres to antiretroviral therapy (ART), their CD4 cell count is elevated and clinical presentation of KS tumors either stabilize or resolve [26] . However, when a patient is on ganciclovir (an antiviral used in the treatment of various forms of herpes) the replication of KSHV is inhibited [27] , although after the manifestation of KS tumors these drugs may not be of use. Confirmed AIDS-KS patients should be on highly active antiretroviral therapy (HAART) to achieve 60-90%
remission [28] . The most likely reason why subjects in this study had KS presentations despite being on ART could be non-adherence or antiretroviral resistance. Kaposi's sarcoma tumors resulting from HIV and AIDS are known to be severe, resistant and are caused by HHV-8 [29] . Typical KS lesions include macules, papules and nodules.
However other morphological variants that have been used to describe it are: patches, plaques, exophytic, infiltrative, keloidal, telangiectatic, cavernous, ulcerative, bullous and verrucous types [30] . For this study, the histological morphology of the KS lesions was nodular, plaques and patches. Majority of the morphological cases were nodular. The distribution of KS in terms of histological morphology was consistent with similar studies that were conducted in Tanzania [31] and Zambia [32] where it was observed that nodular had the most distribution at 68.7%, (82/120) and 60.7% (51/84) respectively. In this study, among those who presented with nodular morphology of KS 61.2% (30) were males and 38.8% (19) females.
These findings were consistent with a study conducted in Uganda [33] where women were less likely to have nodular lesions of KS compared to men. In the Uganda study, reduced rate of KS among females might have been due to gender related factors that include hormonal, environmental or genetic factors.
Conclusion
In conclusion, Kaposi's sarcoma-associated herpes virus (KSHV) genes, K1 and K15 (P) were detected among tissue blocks collected from patients infected with HIV-1 and AIDs. Table 1 : estimated of crude prevalence odds ratio (POR) using simple logistic regression for K1 and K15 (P) genes 
